Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Haymaker Acquisition Corp. III
BTMD | US
1.88
USD-0.20
-9.42%
BTMD | US
About Haymaker Acquisition Corp. III
Sector
Healthcare
Industry
Medical Care Facilities
Earnings date
30/06/2024
As of date
06/03/2026
Close
1.88
Open
2.03
High
2.05
Low
1.86
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone vitamin and mineral levels as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irvine Texas.
View LessBTMD | US
Risk
49.7
Sharpe
-0.85
Luna's Score
31/100
Recommendation
Sell
Luna says (BTMD | US)
What's Working
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
50.3%1 month
49.7%3 months
51.1%6 months
51.7%Returns
Fundamental Ratios
PE
10.64
Fwd. PE
6.73
Price to book
2.96
Debt to equity
-0.85
Debt to assets
1.32
Ent. to EBITDA
8.67
Ent. to rev.
1.39
PEG
-
Other Fundamentals
EBITDA
39.26M
MarketCap
98.68M
MarketCap(USD)
98.68M
Div. yield
-
Op. margin
16.55
Erngs. growth
341.80
Rev. growth
-0.20
Ret. on equity
-
Short ratio
5.05
Short perc.
4.47
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.34
Range1M
0.45
Range3M
1.04
Volumes: Market Activity
Rel. volume
2.20
Price X volume
606.33K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.67 | 13.85 | Cheaper |
| Ent. to Revenue | 1.39 | 1.73 | Par |
| PE Ratio | 10.64 | 22.94 | Cheaper |
| Price to Book | 2.96 | 14.91 | Cheaper |
| Dividend Yield | - | 1.25 | - |
| Std. Deviation (3M) | 51.07 | 51.88 | Par |
| Debt to Equity | -0.85 | 5.15 | Cheaper |
| Debt to Assets | 1.32 | 0.46 | Expensive |
| Market Cap | 98.68M | 6.67B | Emerging |
